Last updated on December 2019

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

Brief description of study

This is a Phase 3, randomized, double-blind, placebo-controlled study to demonstrate the effect of oral ozanimod as maintenance therapy in subjects with moderately to severely active Crohn's Disease.

Clinical Study Identifier: NCT03464097

Find a site near you

Start Over

Digestive Disease Associates, PA

Catonsville, MD United States
  Connect »

Johns Hopkins Bayview Medical Center

Baltimore, MD United States
  Connect »

Woodholme Gastroenterology Associates

Glen Burnie, MD United States
  Connect »